NCT00015171View on ClinicalTrials.gov

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

PHASE3CompletedINTERVENTIONAL
0
Timeline

Start Date

April 30, 1996

Primary Completion Date

May 31, 1997

Study Completion Date

June 30, 1997

Conditions
Heroin DependenceSubstance-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (1)

10010

New York MDRU, New York

All Listed Sponsors
collaborator

New York MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015171 - Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 | Biotech Hunter | Biotech Hunter